Caxton Associates (New York)’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-87,786
| Closed | -$244K | – | 682 |
|
|
2023
Q1 | $244K | Sell |
87,786
-32,348
| -27% | -$89.9K | 0.04% | 382 |
|
|
2022
Q4 | $414K | Buy |
120,134
+24,944
| +26% | +$86.1K | 0.03% | 256 |
|
|
2022
Q3 | $245K | Buy |
+95,190
| New | +$245K | 0.03% | 347 |
|
|
2022
Q1 | – | Sell |
-13,797
| Closed | -$177K | – | 720 |
|
|
2021
Q4 | $177K | Buy |
+13,797
| New | +$177K | 0.02% | 476 |
|